{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T01:29:33Z","timestamp":1755998973108},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2014,10,9]],"date-time":"2014-10-09T00:00:00Z","timestamp":1412812800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s00115-014-4088-5","type":"journal-article","created":{"date-parts":[[2014,10,7]],"date-time":"2014-10-07T08:39:17Z","timestamp":1412671157000},"page":"1352-1362","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Arzneimittelsicherheit"],"prefix":"10.1007","volume":"85","author":[{"given":"M.","family":"Huber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Blumberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Haenisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Schlosser-Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Broich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,9]]},"reference":[{"key":"4088_CR1","unstructured":"Arzneimittelgesetz in der Fassung der Bekanntmachung vom 12.12.2005 (BGBl. I S. 3394), das zuletzt durch Artikel 2a des Gesetzes vom 27.03.2014 (BGBl. I S. 261) ge\u00e4ndert worden ist"},{"key":"4088_CR2","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/archinte.1997.00440350031003","volume":"157","author":"Beers","year":"1997","unstructured":"Beers MH (1997) Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 157:1531\u20131536","journal-title":"Arch Intern Med"},{"key":"4088_CR3","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1370\/afm.1337","volume":"10","author":"Fortin","year":"2012","unstructured":"Fortin M, Stewart M, Poitras ME et al (2012) A systematic review of prevalence studies on multimorbidity: toward a more uniform methodology. Ann Fam Med 10:142\u2013151","journal-title":"Ann Fam Med"},{"key":"4088_CR4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/bmj.38330.470486.8F","volume":"330","author":"Gill","year":"2005","unstructured":"Gill SS, Rochon PA, Herrmann N et al (2005) Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study. BMJ 330:445","journal-title":"BMJ"},{"key":"4088_CR5","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1176\/appi.ajp.161.6.1113","volume":"161","author":"Herrmann","year":"2004","unstructured":"Herrmann N, Mamdani M, Lanct\u00f4t KL (2004) Atypical antipsychotics and risk of cerebrovascular accidents. Am J Psychiatry 161:1113\u20131115","journal-title":"Am J Psychiatry"},{"key":"4088_CR6","first-page":"543","volume":"107","author":"Holt","year":"2010","unstructured":"Holt S, Schmiedl S, Th\u00fcrmann PA (2010) Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int 107:543\u2013551","journal-title":"Dtsch Arztebl Int"},{"key":"4088_CR7","unstructured":"http:\/\/www.bfarm.de\/DE\/Arzneimittel\/Pharmakovigilanz\/RisikenMelden\/uaw\/_node.html. Zugegriffen: 17. Juli 2014"},{"key":"4088_CR8","unstructured":"http:\/\/www.bfarm.de\/DE\/Arzneimittel\/Pharmakovigilanz\/RisikenMelden\/NW-MeldungVerbr\/_node.html. Zugegriffen: 17. Juli 2014"},{"key":"4088_CR9","unstructured":"http:\/\/www.bfarm.de\/SharedDocs\/Downloads\/DE\/Arzneimittel\/Pharmakovigilanz\/Risikoinformationen\/RisikoBewVerf\/a-f\/antipsychotika\/phvwp_ass_report.pdf?__blob=publicationFile&v=2"},{"key":"4088_CR10","unstructured":"http:\/\/www.bfarm.de\/SharedDocs\/Risikoinformationen\/Pharmakovigilanz\/DE\/RV_STP\/stp-escitalopram-neu.html. Zugegriffen: 17. Juli 2014"},{"key":"4088_CR11","unstructured":"http:\/\/www.bfarm.de\/SharedDocs\/Risikoinformationen\/Pharmakovigilanz\/DE\/RV_STP\/stp-antipsychotika-neu.html. Zugegriffen: 17. Juli 2014"},{"key":"4088_CR12","unstructured":"http:\/\/www.bfarm.de\/SharedDocs\/Risikoinformationen\/Pharmakovigilanz\/DE\/RV_STP\/stp-citalopram-neu.html. Zugegriffen: 17. Juli 2014"},{"key":"4088_CR13","unstructured":"http:\/\/www.bundesaerztekammer.de\/page.asp?his=1.100.1143. Zugegriffen: 17. Juli 2014"},{"key":"4088_CR14","unstructured":"http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Report\/2010\/01\/WC500054057.pdf. Zugegriffen: 17. Juli 2014"},{"key":"4088_CR15","unstructured":"http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Report\/2011\/10\/WC500117061.pdf. Zugegriffen: 17. Juli 2014"},{"key":"4088_CR16","unstructured":"http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Report\/2011\/11\/WC500117988.pdf. Zugegriffen: 17. Juli 2014"},{"key":"4088_CR17","unstructured":"http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/news_and_events\/events\/2011\/10\/event_detail_000542.jsp&mid=WC0b01ac058004d5c3. Zugegriffen: 17. Juli 2014"},{"key":"4088_CR18","unstructured":"https:\/\/humanweb.pei.de. Zugegriffen: 17. Juli 2014"},{"key":"4088_CR19","first-page":"18","volume":"2","author":"Huber","year":"2013","unstructured":"Huber M, Keller-Stanislawski B (2013) Der Ausschuss f\u00fcr Risikobewertung im Bereich der Pharmakovigilanz (PRAC). Bull Arzneimittelsicherheit 2:18\u201320","journal-title":"Bull Arzneimittelsicherheit"},{"key":"4088_CR20","unstructured":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (2005) The clinical evaluation of QT\/QTc interval prolongation and proarrhythmic potential for non-arrhythmic drugs \u2013 E14. http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E14\/E14_Guideline.pdf. Zugegriffen: 17. Juli 2014"},{"key":"4088_CR21","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1001\/archgenpsychiatry.2010.30","volume":"67","author":"Jessen","year":"2010","unstructured":"Jessen F, Wiese B, Bachmann C et al (2010) Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment. Arch Gen Psychiatry 67:414\u2013422","journal-title":"Arch Gen Psychiatry"},{"key":"4088_CR22","doi-asserted-by":"crossref","first-page":"e16852","DOI":"10.1371\/journal.pone.0016852","volume":"6","author":"Jessen","year":"2011","unstructured":"Jessen F, Wiese B, Bickel H et al (2011) Prediction of dementia in primary care patients. PLoS One 6:e16852","journal-title":"PLoS One"},{"key":"4088_CR23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/acps.12129","volume":"129","author":"Luck","year":"2013","unstructured":"Luck T, Riedel-Heller SG, Luppa M et al (2013) A hierarchy of predictors for dementia-free survival in old-age: results of the AgeCoDe study. Acta Psychiatr Scand 129:63\u201372","journal-title":"Acta Psychiatr Scand"},{"key":"4088_CR24","first-page":"18","volume":"2","author":"Mergel","year":"2012","unstructured":"Mergel A, Mentzer D, Keller-Stanislawski B (2012) UAW-Meldung durch Patienten \u2013 spezielles Internetportal geplant. Bull Arzneimittelsicherheit 2:18\u201321","journal-title":"Bull Arzneimittelsicherheit"},{"key":"4088_CR25","doi-asserted-by":"crossref","unstructured":"Schaufler J, Telschow C (2013) Arzneimittelverordnungen nach Alter und Geschlecht. In: Schwabe U, Paffrath D (Hrsg) Arzneiverordnungs-Report 2013. Springer, Berlin, S\u00a0967\u2013981","DOI":"10.1007\/978-3-642-37124-0_47"},{"key":"4088_CR26","first-page":"18","volume":"4","author":"Stammschulte","year":"2010","unstructured":"Stammschulte T, Pachl H, Gundert-Remy U et al (2010) Einf\u00fchrung in die Grundlagen der Pharmakovigilanz (Teil II): Spontanmeldesystem zur Erfassung von Verdachtsf\u00e4llen unerw\u00fcnschter Arzneimittelwirkungen (UAW). Bull Arzneimittelsicherheit 4:18\u201326","journal-title":"Bull Arzneimittelsicherheit"},{"key":"4088_CR27","unstructured":"Statistische \u00c4mter des Bundes und der L\u00e4nder (2011) Demographischer Wandel in Deutschland Heft 1\u2013 Bev\u00f6lkerungs- und Haushaltsentwicklung im Bund und in den L\u00e4ndern, Ausgabe 2011. Statistisches Bundesamt, Wiesbaden. http:\/\/www.statistikportal.de\/statistik-portal\/demografischer_wandel_heft1.pdf. Zugegriffen: 17. Juli 2014"},{"key":"4088_CR28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jclinepi.2012.07.019","volume":"66","author":"Van","year":"2013","unstructured":"Van den Bussche H, Sch\u00e4fer I, Wiese B et al (2013) A comparative study demonstrated that prevalence figures on multimorbidity require cautious interpretation when drawn from a single database. J Clin Epidemiol 66:209\u2013217","journal-title":"J Clin Epidemiol"},{"key":"4088_CR29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1024\/1011-6877.22.1.17","volume":"22","author":"Wolter","year":"2009","unstructured":"Wolter DK (2009) Risiken von Antipsychotika im Alter, speziell bei Demenzen \u2013 Eine \u00dcbersicht. Z Gerontopsychol Psychiatrie 22:17\u201356","journal-title":"Z Gerontopsychol Psychiatrie"},{"key":"4088_CR30","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00103-013-1767-5","volume":"56","author":"Zimmermann","year":"2013","unstructured":"Zimmermann T, Kaduszkiewicz H, Bussche H van den et al (2013) Potentially inappropriate medication in elderly primary care patients: a retrospective, longitudinal analysis. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 56:941\u2013949","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-014-4088-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-014-4088-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-014-4088-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T18:53:51Z","timestamp":1565895231000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-014-4088-5"}},"subtitle":["Herausforderung in einer alternden Gesellschaft"],"short-title":[],"issued":{"date-parts":[[2014,10,9]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["4088"],"URL":"https:\/\/doi.org\/10.1007\/s00115-014-4088-5","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,9]]}}}